Valmet Acquires Tissue Rewinder Business From Italian Firm

Valmet Corporation, a leading global developer and supplier of technologies, automation and services for the pulp, paper, and energy industries, has acquired the paper machinery and focus rewinding business from Italian firm, Massimiliano Corsini srl (MC Paper Machinery).
The acquisition is estimated to be completed by August 6, 2015. The acquired operations mainly supply rewinders for tissue and non-woven machines. In the past years, the net sales of the acquired business have been around €10 million. The operations employ 33 people and are located in Pescia, close to Lucca, Italy.
As a result of the acquisition, Valmet will have a more extensive product portfolio and becomes a stronger technology and services company in its field. The acquisition strengthens Valmet’s competitiveness by combining tissue making equipment from stock preparation to rewinding, process know-how, automation and services into one customer value-adding entity, according to a press release.
Valmet and MC Paper Machinery have had a long-term partnership and a large amount of MC Paper rewinders have been installed in connection to Valmet tissue machines. The company being acquired is a strong business, with established customer relations and a high level of technology and know-how, including the successful Focus technology. During the last 20 years MC Paper Machinery has become world leading in designing and manufacturing rewinding plants specifically devoted to the field of non-woven and tissue paper.
Anders Björn, vice president of Valmet’s Tissue Mills Business Unit said, “Valmet and MC Paper Machinery share the same determination to offer leading technologies, with highest customer satisfaction. Through the acquisition, Valmet will become a technology and service company with a wider offering of high technology equipment for tissue production. By combining tissue paper and re-winding machinery with process know-how, automation and services and global presence from both companies, we can serve the tissue producers even better than before and move our customers’ performance forward.” (GK)